Phase 2/3 Study of KPL-387 in Recurrent Pericarditis

NCT07010159 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Pericarditis
Pericarditis Acute
Recurrent Pericarditis

Interventions

DRUG: KPL-387
DRUG: Placebo

Sponsor

Kiniksa Pharmaceuticals International, plc

Collaborators

[object Object]